Bijlagen bij SWD(2012)142 - Implementation of the Health Programme in 2010 - Hoofdinhoud
Dit is een beperkte versie
U kijkt naar een beperkte versie van dit dossier in de EU Monitor.
| dossier | SWD(2012)142 - Implementation of the Health Programme in 2010. |
|---|---|
| document | SWD(2012)142 |
| datum | 23 mei 2012 |
• Procurement (service contracts): these are used to purchase services, such as evaluations, studies, data procurement and IT applications. The Health Programme covers the full cost of these.
Competitive selection and award procedures are used to select actions for funding, with the exception of direct grant agreements and conferences organised by Council Presidencies.
Administrative credits cover expenditure such as studies, meetings of experts, information and publication costs, and technical and administrative assistance for IT systems.
OJLC 358, 31.12.2010, p. 23.
4
4. Implementation of the operational budget by financing mechanism
| Number of grants / contracts signed | Type of financing mechanism | Implementation £ | Share of mecnanism in total executed budget |
| Call for proposals: | ir hi /ill nn 35.313.433.00 | 75.27 vo | |
| zU | Project grants | lo. zz5.jz4.UU | O /I con/ |
| 11 | Conference grants | onn 1 1 O oyy. j jy.uu | i no o/ l.yzyo |
| y | Operating grants | z.jzz. / /4.UU | /i nc 0/ 4.y5 % |
| 1 n 1U | Grants for joint actions | i c qac noA c\c\ | i i 00 0/ j j.öz 70 |
| i n 1U | Direct grant agreements | 4CAA AAA AA 2.600.000.00 | E E 4 O/ 5.54 % |
| Procurement (service contracts) | Q *>11 Jl 1 AA 8.231.411.00 | 17.55 vo | |
| Scientific Committees | 270.000.00 | 0.58 % | |
| Other: JRC | 500.000.00 | 1.07 % | |
| FvprntpH huHpct in 2010 | 46 914 844 00 | ||
| Total available budget | 47 365 553 00 | ||
| Credits not used (pre-accession credits not yet used, differences between amounts in the award decision and amounts actually contracted) | 450.709.00 | ||
| Level of budget execution | 99.05 % |
Call for proposals
for proposals consists of the following parts: a call for proposals for projects, a call for proposals for conferences, a call for proposals for operating grants, a call for proposals for joint actions.
5
The call was launched on 22 December 2009 and closed on 19 May 2010. Announcements were published in the Official Journal5, the Public Health Europa website6 and the EAHC website7.
On 13-14 January 2010 the EAHC organised a workshop in Luxembourg on how to prepare project proposals. Participation was open to those planning to submit proposals. In addition, 11 Member States organised national information days. Guides for applicants were made available on the EAHC website. The EAHC helpdesk also provided assistance and practical help.
In all, 177 applications were submitted for requested funding totalling EUR 117.858 million. The proposals were evaluated in accordance with the rules and criteria set out in Commission Decision 2009/964/EU and the calls for proposals. The proposals were reviewed by 39 external experts drawn from a list that was established following a call for expressions of interest 'Experts for the second programme of Community action in the field of health in various evaluation activities'8.
The evaluation took place in two stages.
In the first stage, three external evaluators reviewed each proposal, and the Commission departments assessed the policy relevance of each of the proposed projects.
In the second stage, an evaluation committee checked that the evaluators had adhered to the relevant rules and criteria. It then drew up final lists of proposals recommended for funding together with reserve lists. The evaluation committee comprised representatives from the Directorate-General for Health and Consumers, the Directorate-General for Research and Innovation, Eurostat and the EAHC.
At its meeting on 7 July 2010 the committee of the second programme of Community action in the field of health (2008-13) issued a favourable opinion on the activities proposed for funding. The Commission adopted the related awarding Decision on 27 October 20109.
Following the amendment of the 2010 work plan on 22 December 2010, a number of additional projects and one joint action were funded from the reserve lists which had been drawn up.
4.1.1. Project grants
In all, 115 proposals were submitted in response to the call for proposals for projects and 17 proposals were recommended for funding. Three proposals were placed on a reserve list. In the end, 20 projects were funded for a total of EUR 16225 324. Their distribution among the programme objectives was as follows:
OJC 313, 22.12.2009, p. 16. .
http://ec.europa.eu/health/programme/application/index_en.htm. http://ec.europa.eu/eahc.
OJ S 28, 9.02. 2008 and http://ec.europa.eu/phea/phea_ami/. http://ec.europa.eu/health/programme/docs/award_decision2010.pdf.
6
- Health security:
EUR 3 534667 (5 projects)
- Health promotion, including the reduction of health inequalities: EUR 12 083 314 (14 projects)
- Health information: EUR 607343 (1 project).
A table in Annex 1 lists the projects funded. The EAHC database, which is publicly accessible on the Internet10, provides abstracts of these.
4.1.2. Conference grants
Apart from 2 Presidency conferences, 27 proposals were submitted in response to the call for proposals for conferences. Of these, 8 were recommended for funding and 2 were put on the reserve list. In the end, 11 conferences were funded for a total of EUR 899339: two Presidency conferences, one under the Belgian Presidency and one under the Hungarian Presidency, and 9 conferences under the call for proposals. The distribution among the programme objectives was as follows:
- Health promotion: EUR 456369 (4 conferences)
- Health information: EUR 442 970 (5 conferences).
The issues addressed in the conferences which were funded included cancer, child health, HIV, injury prevention and patients' rights. A table in Annex 2 lists the conferences funded. The EAHC database provides abstracts of these.
The conference organised by the Belgian Presidency focused on chronic diseases, and the conference organised by the Hungarian Presidency focused on prevention.
4.1.3. Operating grants
A total of 25 proposals were submitted in response to the call for proposals for operating grants. Of these, 6 were renewal applications. In the end, 9 proposals — 5 new proposals and 4 renewal proposals — were funded for a total of EUR 2322774. They all came under the objective 'Health promotion'.
New operating grants were awarded to: Assistance publique des höpitaux de Paris (rare diseases networks: porphyria); Assistance publique des höpitaux de Paris (rare diseases networks: Wilson's disease); the Association of Schools of Public Health in the European Region; European Alcohol Policy Alliance and Stichting Health Action International. Renewals were awarded to: Alzheimer Europe; the European Organisation for Rare Diseases; European Public Health Alliance and Stichting Aids Fonds — Soa Aids Nederland.
Annex 3 contains a table listing the operating grants which received funding. The EAHC database provides abstracts of these.
http://ec.europa.eu/eahc/proiects/database.html.
7
4.1.4. Joint actions
2010 was a record year for joint actions, with 10 being funded for a total of EUR 15 865 996. They were distributed among the programme objectives as follows:
- Health security: EUR 3 600 573 (2 joint actions)
- Health promotion: EUR 10626371 (6 joint actions)
- Health information: EUR 1 639052 (2 joint actions).
These joint actions, with the participation of a large number of Member States and third countries taking part in the Programme, focused on: Alzheimer's; eHealth; European Health and Life Expectancy Information System; cancer; health inequalities; surveillance of congenital anomalies; injury monitoring; organ donation and transplantation; rare diseases and orphan medicines; and the detection of highly infectious pathogens.
All the joint actions selected for funding were signed between 30 December 2010 and 1 August 2011.
Annex 4 contains a table listing the joint actions which were funded. The EAHC database provides abstracts of these.
4.2. Direct grant agreements with international organisations
In all, 5 direct grant agreements were signed for a total of EUR 2 600 000 with the following international organisations:
- Council of Europe — cooperation on substances of human origin;
- European Observatory on Health Policies and Health Systems — Commission membership fee to the Observatory;
- International Agency for Research on Cancer — data, information and knowledge on cancer;
- Organisation for Economic Cooperation and Development — cooperation on key areas of the OECD Health Committee;
- World Health Organization — joint data gathering on the alcohol situation and policies in the Member States.
A table in Annex 5 lists the direct grant agreements which were funded.
4.3. Procurement (service contracts)
Altogether, 79 service contracts were signed for a total of EUR 8231411. They were distributed among programme objectives and IT applications in support of programme implementation as follows:
8
| Programme objective | Tenders / contracts SANCO | Tenders / contracts EAHC | Total |
| Health Security | 596.703 | 763.901 | 1.360.604 |
| Health Promotion | 1.521.438 | 1.312.175 | 2.833.613 |
| Health Information | 1.792.749 | 629.095 | 2.421.844 |
| Information technologies | 1.615.350 | 0 | 1.615.350 |
| Total | 5.526.240 | 2.705.171 | 8.231.411 |
These service contracts covered needs as specified in the work plan for 2010: evaluation and monitoring; studies; provision of advice, data and information on health; scientific and technical assistance; communication and awareness-raising activities and IT applications in support of policy design and implementation.
A table in Annex 6 lists the service contracts which were funded.
4.4. Scientific Committees
The objective of Scientific Committees is to provide the Commission with high quality, independent advice on health risks. Funding from the Health Programme supports the functioning of Scientific Committees in accordance with Commission Decision 2008/721/EC11. Special indemnities are paid to experts for taking part in meetings and their work on scientific opinions.
A sum of EUR 270000 was earmarked for this in 2010.
4.5. Other
Based on an administrative agreement with the Joint Research Centre (JRC), a sum of EUR 500000 went towards work on the Health Emergency and Diseases Information System (Hedis) and the Medical Intelligence System (Medisys).
5. Implementation of the operational budget by programme objectives 5.1. Global budget consumption in 2010
The graph below illustrates the consumption of the budget in 2010 according to the three programme objectives: Health Security, Health Promotion and Health Information. It also covers IT spending and shows the unused budget.
In the following sections the graphs and tables give details of budget consumption according to the three programme objectives.
OJL241, 10.9.2008, p. 21.
9
Implementation of 2010 Health Programme budget per main objective
Non-implemented budget;
Health Promotion; 29.722.441; 63%
10
5.2. Health security — EUR 9.365.844 - 20 % of the operational budget in 2010
Health Security: distribution of committed amounts per priority
Safety of substances of human origin; 8%
Enhancing r capacity
| HEALTH SECURITY | |
| Prevention and control of communicable diseases | 4.712.698.00 |
| Emergency preparedness | 2.276.904.00 |
| Enhancing response capacity | 1.226.491.00 |
| Scientific advice | 429.383.00 |
| Safety of substances of human origin | 720.368.00 |
| TOTAL | 9.365.844.00 |
| Health Programme budget in 2010 | 47.365.553.00 |
11
5.3. Health promotion EUR 29.722.441 - 63 % of the operational budget in 2010
Health Promotion: distribution of committed amounts per priority
Public health
| HEALTH PROMOTION | |
| Public health capacity building | 120.266.00 |
| Reduction of health inequalities | 2.012.743.00 |
| Children and young people | 98.512.00 |
| Health and work | 587.575.00 |
| Nutrition and physical activity | 1.993.418.00 |
| Mental health | 3.420.534.00 |
| Major and chronic diseases | 6.017.458.00 |
| Rare diseases | 9.005.328.00 |
| Sexual health and HIV-AIDS | 1.239.960.00 |
| Tobacco | 489.432.00 |
| Alcohol | 1.124.441.00 |
| Illicit drugs | 900.000.00 |
| Injury prevention | 1.712.774.00 |
| TOTAL | 29.722.441.00 |
| Health Programme budget in 2010 | 47.365.553.00 |
12
5.4.
Health information —
EUR 6.211.209 - 13 % of the operational budget in 2010
Health Information: distribution of commited amounts per priority
Analysis and reporting;
European H Information S;
40,2%
| HEALTH INFORMATION | |
| Exchange knowledge and best practice | 568.840.00 |
| Collect, analyse and disseminate health information | 2.810.425.00 |
| European Health Information System | 2.494.357.00 |
| Dissemination and application of health information | 332.787.00 |
| Analysis and reporting | 4.800.00 |
| TOTAL | 6.211.209.00 |
| Health Programme budget in 2010 | 47.365.553.00 |
13
ANNEX 1 -Project grants (signed and committed)
| HEALTH SECURITY | ||
| 3.2.1.1. Prevention and control of communicable diseases | ||
| Acronym | Title | Amount |
| HProImmune | Promotion of immunisation for Health Professionals in Europe | 603 900 |
| EU-HEP-SCREEN | Screening for Hepatitis B and C among migrants in the European Union+ | 792816 |
| 3.2.1.2. Emergency preparedness | ||
| FLURESP | Cost-effectiveness assessment of European influenza human pandemic alert and response strategies | 699220 |
| PHASE | Public Health Adaptation Strategies to Extreme weather events | 744038 |
| 3.2.1.3. Enhancing response capacity | ||
| TUBIDU | Empowering Civil society & Public Health system to fight tuberculosis Epidemic Among Vulnerable groups | 694693 |
| Total | 3534667 | |
| HEALTH PROMOTION | ||
| 3.3.2. Promote healthier ways of life and reduce major diseases and injuries by tackling health determinants | ||
| 3.3.2.2. Health and work | ||
| PHWork | Promoting Healthy Work for Employees with Chronic Illness — Public Health & Work | 587 575 |
| 3.3.2.3. Nutrition and physical activity | ||
| MOVE | European Physical Activity Promotion Forum | 676020 |
| SALUS | A European network to follow up the reformulation of food. Identification & Exchange of good practices for SMEs & Consumers | 834688 |
| 3.3.2.5. Mental health | ||
| PRO YOUTH | Promotion of young people's mental health through technology-enhanced personalisation of care | 930378 |
14
| EUROGENAS | European regions enforcing actions against suicide | 750000 |
| PREDI-NU | Preventing Depression and Improving Awareness through Networking in the EU | 1099032 |
| 3.3.2.7 Prevention of maj | or and chronic diseases and rare diseases | |
| Major and chronic diseases | ||
| EuroHeart II | European Heart Health Strategy II | 1 149364 |
| Rare diseases | ||
| E-IMD | European registry and network for Intoxication type Metabolic Diseases | 779746 |
| EURO-WABB | An EU rare diseases registry for Wolfram syndrome, Alstrom syndrome & Bardet Biedl syndrome | 900000 |
| EPIRARE | Building Consensus and Synergies for the EU Registration of Rare Disease patients | 661402 |
| EUReMS | European Register for Multiple Sclerosis — A tool to assess, compare and enhance the status of people with MS throughout the EU | 987198 |
| 3.3.2.4. Sexual health and HIV-AIDS | ||
| SIALON II | Capacity building in combining targeted prevention with meaningful HIV surveillance among MSM | 989960 |
| 3.3.2.6. Addiction prevention | ||
| Illicit drugs | ||
| NEW Implementation | Nightlife Empowerment and Well-being Implementation project | 900000 |
| 3.3.2.9. Injury prevention | ||
| TACTICS | Tools to address childhood Trauma, Injury and Children's Safety | 837951 |
| Total | 12083314 | |
| HEALTH INFORMATION | ||
| 3.4.2. Collect, analyse and disseminate health information | ||
| EURO-PERISTAT | Promoting better health for mothers and babies through routine European monitoring of perinatal health and health care | 607343 |
| Total | 607343 | |
| TOTAL PROJECTS | 16225324 |
15
ANNEX 2 — Conference grants (signed and committed)
| HEALTH PROMOTION | - | |
| 3.3.1. Foster healthier ways of life and reduce health inequalities | ||
| 3.3.1.3. Reduction of health inequalities | ||
| Acronym | Title | Amount |
| Bridges for CHILD | CHILD-Combating Health Inequalities in Life-threatening diseases | 96500 |
| 3.3.2. Promote healthier ways of life and reduce major diseases and injuries by tackling health determinants | ||
| 3.3.2.1. Children and young people | ||
| YEP — Youth Cancer Conference | Cancer Education and Awareness for all Young People | 49869 |
| 3.3.2.6. Addiction prevention — Tobacco | ||
| ECToH2011 | European Conference on Tobacco or Health 2011 | 50000 |
| 3.3.2.9. Injury prevention | ||
| InjuryConf-2011 | Tackling the challenges of implementing good practices in safety promotion — EUROSAFE | 85 000 |
| Presidency conferences | ||
| Chronic diseases — BE | Innovative approaches for chronic illness in Public health and healthcare systems | 100000 |
| PREVACT — HU | Action for Prevention | 75 000 |
| Total | 456369 | |
| HEALTH INFORMATION | ||
| 3.4.1. Exchange knowled | ^e and best practice | |
| AIDS 2011 | HIV in Europe — unity and diversity | 100000 |
| ccc | Continuing Cancer Care | 20845 |
| Copenhagen 2011 | Fourth Joint European Public Health Conference | 150000 |
| EU Patients and Rights Day | 5th European Patients and Rights Day: Putting Citizens at the Centre of EU Health Policy | 75125 |
| FEMP2011 | Men, Men, Sex and HIV 2011 — The Future of European MSM Prevention | 100000 |
16
| Total | 442970 |
| TOTAL CONFERENCES | 899339 |
EN
17
EN
ANNEX 3 -Operating grants (signed and committed)
| HEALTH PROMOTION | ||
| 3.3.1. Foster healthier ways of life and reduce health inequalities | ||
| 3.3.1.2. Public health capacity building | ||
| Acronym | Title | Amount |
| EPHA | European Public Health Alliance — renewal OG 2009 | 550000 |
| HAI | Stichting Health Action International | 218000 |
| ASPHER | The Association of Schools of Public Health in the European Region | 160000 |
| 3.3.2.7. Prevention of major and chronic diseases and rare diseases | ||
| Major and chronic diseases | ||
| AE | Alzheimer Europe — renewal OG 2009 | 200000 |
| Rare diseases | ||
| AP-HP WILSON | Rare diseases network — Wilson's disease; Assistance publique des höpitaux de Paris | 168160 |
| EURORDIS | European Organisation for Rare Diseases — renewal OG 2009 | 580000 |
| AP-HP Porphyria | Rare diseases network — Porphyria; Assistance publique des höpitaux de Paris | 99250 |
| 3.3.2.4. Sexual health and HIV-AIDS | ||
| SANL | Stichting Aids Fonds ~ Soa Aids Nederland — renewal OG 2009 | 250000 |
| 3.3.2.6. Addiction prevention | ||
| Alcohol | ||
| EUROCARE | European Alcohol Policy Alliance | 99000 |
| TOTAL OPERATING GRANTS | 2322774 |
18
ANNEX 4 -Joint actions (signed and committed)
| HEALTH SECURITY | ||
| 3.2. Improve citizen's health security | ||
| 3.2.2. Improve citizen's safety | ||
| Acronym | Title | Amount |
| MODE | Mutual Organ Donation and Transplantation Exchanges | 293 060 |
| 3.2.1.1. Prevention and control of communicable diseases | ||
| QUANDHIP | Quality Assurance Exercises and Networking on the Detection of Highly Infectious Pathogens | 3315982 |
| Total | 3600573 | |
| HEALTH PROMOTION | ||
| 3.3.1. Foster healthier ways of life and reduce health inequalities | ||
| 3.3.1.3. Reduction of health inequalities | ||
| EQUITY ACTION | Joint Action on Health Inequalities | 1700000 |
| 3.3.2.7 Prevention of major and chronic diseases and rare diseases | ||
| Major and chronic diseases | ||
| EPAAC | European Partnership for Action Against Cancer | 3212278 |
| ALCOVE | ALzheimer Cooperative Valuation in Europe | 638163 |
| Rare diseases | ||
| EUROCAT | European Surveillance of Congenital Anomalies | 1106302 |
| ORPHANET | European portal of rare diseases and orphan drugs | 3 295 857 |
| 3.3.2.9. Injury prevention | ||
| JAMIE | Joint Action on Monitoring Injuries in Europe | 790773 |
| Total | 10626371 | |
| HEALTH INFORMATION | ||
| 3.4.2. Collect, analyse and disseminate health information | ||
| EHLEIS | European Health and Life Expectancy Information System | 643 259 |
19
| 3.4.2.1. European Health Information System | ||
| JA- EHGov | Joint Action eHealth Governance Initiative | 1001970 |
| Total | 1639052 | |
| TOTAL JOINT ACTIONS | 15865996 |
20
ANNEX 5 -Direct grant agreements with international organisations (signed and committed)
| HEALTH SECURITY | ||
| 3.2.2.3. Safety of substances of human origin | ||
| Organisation | Title | Amount |
| Council of Europe | Cooperation with the CoE on specific matters related to human substances | 100000 |
| Total | 100000 | |
| HEALTH PROMOTION | ||
| 3.3.2. Promote healthier ways of life and reduce major diseases and injuries by tackling health determinants | ||
| 3.3.2.7. Prevention of major and chronic diseases and rare diseases | ||
| Major and chronic diseases | ||
| I ARC | Data, information and knowledge on cancer | 800000 |
| 3.3.2.6. Addiction prevention | ||
| Alcohol | ||
| WHO | Cooperation between the EC and the WHO Regional Office for Europe on further development of joint data gathering and common knowledge base relating to the alcohol situation and alcohol policies in Member States | 600000 |
| Total | 1400000 | |
| HEALTH INFORMATION | ||
| 3.4.2. Collect, analyse and disseminate health information | ||
| OECD | Cooperation on key areas of work of the Health Committee of the OECD | 600000 |
| Observatory | European Observatory on Health Policies and Health Systems — Membership Fee | 500000 |
| Total | 1100000 | |
| TOTAL DIRECT GRANTS | 2600000 |
21
ANNEX 6 — List of service contracts — procurement (signed and committed)
| HEALTH SECURITY | - |
| 3.2.1.2. Emergency preparedness | |
| Title | Amount |
| Organisation of training of staff and conducting exercises at European level as a fundamental element of preparedness — HPA | 333 646 |
| 3.2.1.3. Enhancing response capacity | |
| Developing evidence-based, scientifically validated public health counter-measures | 243 610 |
| Establishing risk assessment networks of toxic industrial chemicals and radioactive threats and risks | 249534 |
| Specific contract lab exercises | 38654 |
| 3.2.2.2. Scientific advice | |
| Literature search — publications health and environment | 12372 |
| Editorial guidelines layout opinions | 8 847 |
| Editorial work on rules of procedure for scientific committees | 1577 |
| Investigate the scientific basis for the term 'nanomaterials' | 7171 |
| Literature search for sources on mixture toxicity | 8306 |
| Editorial support for the SCENIHR opinion on nanomaterials | 2763 |
| Editorial support — food-imitating products | 2763 |
| Editorial support for the SCENIHR opinion on weight of evidence | 2154 |
| Editorial work on SCENIHR opinion — artificial light | 3381 |
| Editorial support for opinion on TTC | 2000 |
| Editorial support for opinion on fluoridation | 2309 |
| Editorial support for opinion on risk assessment | 1536 |
| Web-based text - opinion of non-food committee | 17645 |
| Literature search — nitrosamine | 11439 |
| Literature search — nitrosamine | 14023 |
| Data on nano effects | 12310 |
| Literature search — nanomaterials in medical devices | 11137 |
| Complementary commitment for Media Consulta 2009 | 13 500 |
22
| Literature search — health effects of swimming pools | 4835 |
| Literature search — health effects of aircraft cabins | 4835 |
| CD Rom and newsletter | 8177 |
| Synthetic biology workshop | 6303 |
| 3.2.2.3. Safety of substances of human origin | |
| Training health professionals | 270757 |
| Banner organ donation | 18756 |
| Workshop 2011 — Ligaris on organ donation | 23 000 |
| Workshop 2011 — Ligaris on organ donation | 23 264 |
| Total | 1360604 |
| HEALTH PROMOTION | |
| _ 3.3.1. Foster healthier ways of life and reduce health inequalities | |
| 3.3.1.2.Public health capacity building | |
| Expertise, advice and production of scientific data | 58796 |
| Use of existing framework contract with the EPHA for the Health Forum | 134106 |
| 3.3.1.3. Reduction of health inequalities | |
| Preparation of a report on health inequalities in the EU | 249948 |
| 3.3.2. Promote healthier ways of life and reduce major diseases and injuries by tackling health determinants | |
| 3.3.2.1. Children and young people | |
| Conference on Youth Health Initiative 2010 — Food for Mind — Mind for Health — 22-24/10/2010 — Torino | 48643 |
| 3.3.2.3. Nutrition and physical activity | |
| Sharing of know-how on Community based initiatives to reduce overweight and obesity | 74294 |
| Belgian Presidency Conference on Nutrition 8-9.12.2010 — Ligaris | 99815 |
| Use of existing framework contract with EVENT TECH for nutrition and physical activity | 233 601 |
| 3.3.2.5. Mental health | |
| Study, in three parts, assessing mental health systems, situations and outcomes in Member States | 299507 |
| Berlin Conference on mental health — 3-4/3/2011 | 99300 |
| Scientific contract for conference in Berlin on mental health | 72594 |
| Conference in Lisbon, expert advice, production of scientific documentation | 69729 |
23
| Organisation of Lisbon conference | 99994 |
| 3.3.2.7 Prevention of major and chronic diseases and rare diseases | |
| Rare diseases | |
| Orphan medicines | 181295 |
| Orphan medicines — Creation of a mechanism for the exchange of knowledge between Member States and European authorities on the scientific assessment of the clinical added value for orphan medicines | 247118 |
| 3.3.2.6. Addiction prevention | |
| Tobacco | |
| Support for the implementation of EU policy on tobacco control, in particular in raising awareness of health risks | 5 000 |
| 2 studies on cigarette packaging | 369000 |
| Availability, accessibility, usage and regulatory environment for new tobacco and nicotine products | 65432 |
| Alcohol | |
| EU-wide overview of the market and regulation regarding types of alcoholic beverages with particular appeal to minors | 99979 |
| Studies on the affordability of alcoholic beverages | 94602 |
| European Alcohol & Health forum — scientific work first semester | 89392 |
| European Alcohol & Health forum | 115568 |
| Assessing quality of 2010 monitoring activities by members of EAHF | 25 900 |
| Total | 2833613 |
| HEALTH INFORMATION | |
| 3.4.1. Exchange of knowledge and best practice | |
| Participation in the 20th IUHPE world conference on health, Geneva | 125 870 |
| 3.4.2. Collect, analyse and disseminate health information | |
| Evaluation of the impact of Structural Funds investments on health gains | 467570 |
| 5 Eurobarometers (electromagnetic fields, rare diseases, mental health, patients' rights, tobacco) | 1098354 |
| 3.4.2.1. European Health Information System | |
| Mutual Recognition of Medical Prescriptions: State of Play | 161525 |
| Study in support of the identification and development of a non-exhaustive list of elements to be included in prescriptions | 110938 |
24
| Level 1 commitment for WIKI project | 120000 |
| 3.4.2.2. Dissemination and application of health information | |
| Provisional journalist prize | 25 000 |
| Publication Journal: Promotion of the portal on the Agenda of Journalists of Italy | 1600 |
| Publication Journal: Promotion of the portal on the Agenda of Journalists of BE NL | 1250 |
| Publication Journal: Promotion of the portal on the Agenda of Journalists of BE FR | 1250 |
| Video and DVD 'Health in all policies' | 57970 |
| Schema directeur comm | 36318 |
| Conference on global health Banner | 17674 |
| Third European Public Health Conference | 26764 |
| European Health forum Gastein 6-9 Oct 2010 | 164961 |
| 3.4.3. Analysis and reporting | |
| Impact of youth health on EU economy | 4800 |
| Total | 2421844 |
| IT applications in support of programme implementation | |
| Service providers | 1615350 |
| Total | 1615350 |
| TOTAL PROCUREMENT (SERVICE CONTRACTS) | 8231411 |
25
Appendix Annual Report 2010 Key results of actions funded under the Health Programme
EN
1
EN
TABLE OF CONTENTS
1. Health Security.............................................................................................................3
1.1. European Union Standards and Training for the Inspection of Tissue Establishments — project......................................................................................................................3
1.2. Increasing Public Health Safety for the External Borders of an Enlarged European Union — project...........................................................................................................4
1.3. European Network for Highly Infectious Diseases — project.....................................4
2. Health Promotion.........................................................................................................5
2.1. EuroHeart — proj ect....................................................................................................5
2.2. Europl an — proj ect......................................................................................................6
2.3. European Organisation for Rare Diseases (EURORDIS) — operating grant..............7
2.4. Alzheimer Europe — operating grant..........................................................................8
3. Health information.......................................................................................................9
3.1. EU Network on Health Technology Assessment — Joint action................................9
3.2. eHealth Presidency Conference.................................................................................10
2
The following projects produced key results in 2010 and represent all strands. 1. Health Security
1.1. European Union Standards and Training for the Inspection of Tissue Establishments — project
http://www.sohovs.org/soho/mod/resource/view.php?id=43
Programme Objective: Health Security. Area: Substances of human origin.
The project was funded under the first Public Health Programme 2003-2008, under the 2005 work plan, with total cofunding from the EU of €1.226.827. It started in December 2006 and ended in December 2009.
Background information
The European Union Standards and Training for the Inspection of Tissue Establishments project (EUSTITE) is an example of EU-wide cooperation in the area of public health directly related to EU legislation, and specifically Directive 2004/23/EC on substances of human origin and its associated implementing directives. To ensure the quality and safety of blood, tissues and cells, all Member States are obliged to comply with the standards laid down in EU legislation.
The objective of the project was to review the standards and methods applied by the national competent authorities in the inspection and authorisation of tissue procurement and tissue establishments within the EU, by bringing together a wide consortium of 11 organisations from 10 EU Member States and the World Health Organization, to analyse their advantages and disadvantages.
Main achievements
The project produced significant results, based on an initial analysis which showed that national inspection systems are at very different stages of development and highlighted the considerable disparities between Member States in the implementation of common legislation.
While recognising these differences in approach and acknowledging their advantages and disadvantages in national practice, the project contributed to the need for guidelines and training on how to conduct inspections in order to ensure a common approach. This approach was strengthened as a result of the following deliverables and guides made available in 2010.
• Guidelines for the inspection of tissue and cells procurement establishments.
• Guidelines for national competent authorities.
• EUSTITE inspector training programme for tissue and cells inspectors.
• Implementation guides for the tissues and cells directives.
• International tissue and cell distribution.
• Common reporting system for serious adverse events and reactions.
3
1.2. Increasing Public Health Safety for the External Borders of an Enlarged European Union — project
http://www.iom.int/iahia/webdav/shared/shared/mains^ Summarv-Brief-011209.pdf
Programme Objective: Health Security. Area: Cross-Border Health Threats.
The project was funded under the first Public Health Programme 2003-2008, under the 2006 work plan, with total funding from the EU of €471.076. The project started in June 2007 and was concluded in June 2010.
Background information
The EU faces increased and more complex migration flows. The inherent challenges have been amplified through the enlargement of the Schengen zone. Health systems and border services need to be prepared to address general public health concerns. They need also to respond to the health needs and rights of migrants, while at the same time safeguarding their own staffs occupational health.
The project 'Increasing Public Health Safety for the External Borders of an Enlarged European Union' (PHBLM) first assessed the magnitude and nature of current public health threats and hazards in border regions, and identified the needs for improvement and structural change. The safety and healthcare of border management staff and migrants themselves were at the heart of the recommendations of the project, which further developed a comprehensive public health and border management module.
Main achievements
• A protocol for assessing public health conditions and related health hazards.
• Guidelines for public health aspects of border management and detention procedures.
• Recommendations for structural changes in border management and controls involving the movement of persons, with a view to improving public health risk assessment and management in the new Schengen II covering the Eastern external borders of the EU.
• Training materials on aspects of migration health in border management.
1.3. European Network for Highly Infectious Diseases — project
Programme Objective: Health Security. Area: Cross-B order Health Threats.
The project was funded under the first Public Health Programme 2003-2008, under the 2006 work plan, with total co-funding from the EU of €361.925.20. The project started in July 2007 and ended in December 2010.
Background information
The occurrence of highly infectious diseases represents a serious cross-border health threat with a possible high impact on health and the economy. Experience has highlighted the critical importance of the hospital setting: almost all the patients requiring isolation were
4
initially admitted to a general hospital without adequate isolation facilities and later transferred to a high-level isolation unit. The project revealed a high level of heterogeneity as well as weaknesses in terms of recognition, public health response and diagnostic and clinical management. Nevertheless, the proper application of infection-control measures greatly reduces the risk of transmission of contagious diseases in hospital settings.
The objective of the European Network for Highly Infectious Diseases (EURONHID) was to create a network of national centres, identified within the participating EU Member States, as high-level isolation units or reference hospitals involved in the care of patients affected by highly infectious diseases12.
Main achievements
The project comprised partners from 16 Member States, bringing together a significant group of European clinicians experienced in the management of highly infectious diseases and high-level isolation units. It contributed to initiating and enhancing collaboration, communication and exchange of information among the highly specialised staff of the participating centres and establishing a wide reference network.
The major outputs from this project were:
• Assessment of hospitals' preparedness and assessment of current capabilities, based on a commonly agreed checklist for data collection and data analysis.
• A manual for the safe and appropriate management of patients suffering from highly infectious diseases in isolation facilities.
• Consensus proposals for affordable and sustainable improvements to ensure bio safety and bio security.
2. Health Promotion 2.1. EuroHeart — project
http://www.ehnheart.org/euroheart/about.html
Programme Objective: Health Promotion. Area: Cardiovascular disease.
The project was funded under the 2006 work plan of the first Public Health Programme 2003-2008, with total co-funding from the EU of €1.023.993. The project started in April 2007 and finished in March 2010.
Background information
HIDs list: Viral Haemorrhagic Fever (marburgvirus, ebolavirus, Crimean-Congo haemorrhagic fever virus, and Lassa virus), and South American haemorrhagic fever (Junin, Machupo, Sabia, and Guanarito) viruses; SARS Co-V; multi-drug resistant M tuberculosis (known or suspected infection); emerging highly pathogenic strains of influenza virus; smallpox and other orthopox infections (eg, monkey pox, camel pox, but excluding vaccinia virus); other emerging, highly pathogenic, agents, including agents of deliberate release (e.g. pneumonic plague).
5
Cardiovascular disease (CVD) remains the leading cause of mortality in the European Union, accounting for over 2 million deaths every year. Building on developments in the area of tobacco, alcohol and nutrition/physical activity, the European Heart Network and the European Society of Cardiology agreed to pool their expertise in a joint project called EuroHeart. The objective of the project was to address the significant problem of CVD in Europe and to determine specific areas of intervention aimed at preventing avoidable deaths and disability. It involved partners in 21 EU countries as well as Iceland, Norway and Turkey.
Main achievements
• The European Heart Health Charter (http://www.ehnheart.org/euroheart/european-health-charter.html) was launched in 30 countries and translated into 24 languages, mobilising broad support for CVD prevention and strengthening cross-sector cooperation.
• The partners carried out studies to obtain comprehensive and comparable information on policies and measures with respect to CVD prevention through mapping and analysing national plans, policies and measures across Europe. (http://www.ehnheart.org/euroheart/publications-wp-5-wp-6/publication/119-cvd-prevention-in-europe-the-unfinished-agenda.html)
• Significant efforts were deployed to improve the awareness, diagnosis and treatment of CVD among women. A report 'Red Alert for Women's Hearts' (http://www.ehnheart.org/euroheart/publications-wp-5-wp-6/publication/117-red-alert-on-womens-hearts.html) shows that heart disease and stroke are the leading causes of female mortality worldwide. However, the risk for women is largely underestimated by the general population, and often by the medical profession itself, because women usually suffer from CVD 10 years later in their life than men do.
• The 'Heartscore' was rolled out throughout Europe (www.HeartScore.org). This is a very simple tool which is used to define an individual's risk of CVD.
The results of this project were presented to Members of the European Parliament, at the April 2010 meeting of the MEP Heart Group in Brussels.
2.2. Europlan — project
http ://www. europlanproj ect. eu/Home. aspx
Programme Objective: Health Promotion. Area: Rare Diseases.
The project was funded under the 2007 work plan of the first Public Health Programme 2003-2008, with total cofunding from the EU of €640.000. It started in April 2008 and ended in March 2011.
Background information
The main goal of the Europlan project was to provide national health authorities in the Member States with supporting tools for the development and implementation of National
6
Plans and Strategies for rare diseases in line with the Council Recommendation on Rare Diseases13.
The main objectives of the project were:
• to stimulate discussion and reach a consensus on the importance of national plans for structuring all relevant actions in the field of rare diseases;
• to promote the development of national plans or strategies for rare diseases within EU Member States;
• to provide an instrument to support countries in designing national plans or strategies for rare diseases in accordance with the Council Recommendation 13.
Main achievements
• Organisation of 15 national conferences, throughout the EU, bringing together national stakeholders, patient representatives, public health authorities, clinicians and other health professionals, as well as researchers and other experts to promote concerted action in the area of rare diseases. The conferences raised awareness of rare diseases as a public health issue with a European dimension, and contributed to the creation of momentum to launch new activities or consolidate existing activities, initiatives or policies. They also enabled stakeholders to make full use of the tools developed by the Europlan project: a guide with recommendations for the definition and implementation of national plans and strategies for rare diseases; a report on current practices and relevant cases in the field of rare diseases; and a recommended set of indicators for monitoring and evaluating the implementation of national initiatives.
More information on the 15 conferences can be found at:
http://www.europlanproject.eu/ContenutoPage/104/en-GB/project/national-conferences-to-
discuss-europlan-supporting-tool-locations.aspx.
• A report on the state of the art of rare disease activities in the EU27 (http://www.eucerd.eu/upload/file/Reports/2011ReportStateofArtRDActivities.pdf) was coproduced by the Europlan project and the Joint Action on the scientific secretariat of the rare disease taskforce (funded under the 2008 annual work plan with total EU cofinancing of €749.162). The report lists all measures put in place by all EU Member States, whether through a fully-fledged national plan for rare diseases or through sets of coordinated activities in all areas, including basic and clinical research, health services development and practice, public health policy and patient support.
2.3. European Organisation for Rare Diseases (EURORDIS) — operating grant
http://www.eurordis.org/
Programme Objective: Health Promotion. Area: Rare Diseases.
European Council Recommendation on an action in the field of Rare Diseases (2009/C 151/02).
7
The operating grant, funded under the 2009 work plan of the second Health Programme 2008-2013, cofinanced the operation of EURORDIS during 2010 with a total EU contribution of €733.000. Duration of the grant: January — December 2010.
Background information
The European Organisation for Rare Diseases (EURORDIS) is a non-governmental patient-driven alliance of organisations representing more than 492 rare disease patient organisations in over 46 countries. The mission of EURORDIS is to build a strong pan-European community of patient organisations and people living with rare diseases, to be their voice at European level, and — directly or indirectly — to mitigate the impact of rare diseases on their lives.
Main achievements
The European Conference on Rare Diseases, held in Krakow in May 2010, was funded from the operating grant awarded to EURORDIS. It brought together more than 600 participants from 43 different countries, including the US, Canada, Israel, Tunisia and Argentina. The conference focused on four fundamental strategic issues for the European rare diseases community:
• developing and implementing national plans for rare diseases;
• establishing national centres of expertise and European reference networks;
• supporting research and treatments;
• disseminating information and developing specialised services.
These areas need better policies in order to meet the objectives of the Council recommendation14 and build momentum for national plans and strategies to be implemented across Europe.
More information can be found at http://www.eurordis.org/content/european-conference-rare-diseases-%E2%80%93-ecrd-2010-krakow.
2.4. Alzheimer Europe — operating grant
http ://www. alzheimer-europe. org/
Programme Objective: Health Promotion. Area: rare diseases.
The operating grant, which was funded under the 2009 work plan of the second Health Programme 2008-2013, cofinanced the operation of Alzheimer Europe during 2010 with a total EU contribution of €250.000. Duration of the grant: January — December 2010.
Background information
European Council Recommendation on an action in the field of Rare Diseases (2009/C 151/02).
8
As the European organisation representing the interests of people with dementia and their carers, the key aim of Alzheimer Europe is to make dementia a European priority. In its campaign, Alzheimer Europe used the results of European projects, such as the 'European collaboration on dementia — EuroCoDe' project or surveys of carers of people with dementia in different European countries. Alzheimer Europe currently has 35 member associations from 31 countries across Europe.
Main achievements
• The operating grant focused on the collection of national legislation and the exchange of good practice in the care and treatment of people with Alzheimer's. Activities focused on the promotion of mental health and the fight against stigma.
• The organisation also focused on the mental health of older people in the European Pact for mental health and well-being and its priorities of promoting the active inclusion of people with mental health problems in society and taking measures to support carers.
• Alzheimer Europe established a network to help carers deal with ethical issues arising in the care of people with dementia, identify a way of promoting the active participation of people with dementia and carry out an inventory of laws on guardianship and proxy decision-making in the Member States of the European Union.
• Alzheimer Europe also ensured that information on best practice in the care of Alzheimer's sufferers is available throughout Europe and beyond.
3. Health information
3.1. EU Network on Health Technology Assessment — Joint action
http ://www. eunethta. eu/
Programme Objective: Health information. Area: Health Technology Assessment.
The Joint Action was funded under the second Health Programme 2008-2013, under the 2009 work plan, with total cofunding from the EU of €2.979.655. The project started in December 2009 and is expected to end by December 2012.
Background information
Health technology is the application of scientific knowledge to health care and disease prevention. Health technology assessment (HTA) is a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of health technology in a systematic, transparent, unbiased and robust manner. Its aim is to inform the formulation of safe, effective health policies that are patient-focused and seek to achieve best value. Despite its policy goals, HTA must always be firmly rooted in research and the scientific method.
The Joint Action on HTA is part of the global action developed by DG SANCO to help support a coordinated network of most of the EU HTA agencies. This Joint Action aims to:
9
• produce clear guidelines on what can be better achieved on HTA at EU level;
• avoid duplication of work between national agencies;
• spread expertise for the benefit of all EU countries;
• strengthen evaluations carried out by EU countries;
• develop transparent governance tools, in particular vis a vis stakeholders;
• produce a number of joint scientific assessments on interventions, medical devices and pharmaceuticals;
• implement the Pharmaceutical Forum's recommendations on the relative effectiveness of pharmaceuticals.
Main achievements
• The first project on cooperation in the area of HTA (EUnetHTA) had already
developed a core model presenting a catalogue of standardised tools and methodologies used in HTA. To complement this initial effort, it was necessary to establish a basis for more structured and long-term collaboration in the field. Thus the common core model could be extended and used for commonly developed and delivered assessments of technologies or processes.
• The development of a tri-annual work plan as the network's consolidated organisational basis for the future.
• Establishment of a set of standard operating procedures for structuring collaboration between HTA agencies and development of a stakeholder involvement policy aimed at making the process more transparent.
• Completion of a set of technical tools, such as a web-based toolkit and an information management system.
3.2. eHealth Presidency Conference
Programme Objective: Health Information. Area: eHealth.
The Presidency Conference took place in Barcelona on 15-18 March 2010. It was funded under the 2009 work plan of the second Health Programme 2008-2013, with total co-funding from the EU of €100.000.
Background information
The Spanish Presidency organised a high-level conference on eHealth, simultaneously bringing together the two most important European events in the eHealth area:
• the High Level European Union Conference (EU) on eHealth;
10
• the World of Health IT (WoHIT), where the ICT world can meet businesses and
health-care institutions and professionals, in parallel with eHealth Week in Barcelona in 2010 (www.ehealthweek2010.org).
Main achievements
Under the slogan 'eHealth for sustainable healthcare: global changes through local actions', this ministerial conference acknowledged the urgent challenges of a rapidly ageing European society, the lack of prevention and prediction of illnesses and the growing demand for quality of care. It also reiterated the need for rapid use of ICT as a cost-effective means of improving the health of European citizens while supporting the work of health care professionals. Thus, it helped to foster the adoption of eHealth in Europe and improve the accessibility, quality and efficiency of healthcare services for patients in Europe.
A key outcome of the conference was the adoption of the European declaration 'Cooperation for eHealth' to promote eHealth and digital health. The declaration shows that the introduction and development of ICT in the healthcare area are not only the result of a political and strategic commitment to improve public health in Europe, but are also intended to link eHealth policies to policies of competitiveness, innovation and research. It is also necessary to foster the cohesion, social inclusion and sustainability of health systems in the EU.
11